journal cover

Study partner-reported decline identifies cognitive decline and dementia risk

Annals of Clinical and Translational Neurology

Nov 13, 2019

Rachel L NoshenyAlzheimer’s Disease Neuroimaging Initiative investigators

Get paper from

Abstract

Identifying individuals at risk for cognitive decline, Mild Cognitive Impairment (MCI), and dementia due to Alzheimer's disease (AD) is a critical need. Functional decline is associated with risk and can be efficiently assessed by participants and study partners (SPs). We tested the hyp...read more

Mentioned in this Paper

Alzheimer's Disease
Apolipoprotein E
Biological Markers
Brain
Electrocochleography
Neuropsychological Tests
Impaired Cognition
Dementia
Participant
Mild Cognitive Disorder
3
1
Paper Details
References
  • References46
  • Citations
12345
  • References46
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Study partner-reported decline identifies cognitive decline and dementia risk

Annals of Clinical and Translational Neurology

Nov 13, 2019

Rachel L NoshenyAlzheimer’s Disease Neuroimaging Initiative investigators

PMID: 31721455

DOI: 10.1002/acn3.50938

Abstract

Identifying individuals at risk for cognitive decline, Mild Cognitive Impairment (MCI), and dementia due to Alzheimer's disease (AD) is a critical need. Functional decline is associated with risk and can be efficiently assessed by participants and study partners (SPs). We tested the hyp...read more

Mentioned in this Paper

Alzheimer's Disease
Apolipoprotein E
Biological Markers
Brain
Electrocochleography
3
1

Related Papers

Paper Details
References
  • References46
  • Citations
12345
  • References46
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/study-partner-reported-decline-identifies/31721455